Nadia Yimer, MD
Pulmonary Disease · Winder, GANPI 1073000618
Payments from drug & device makers
What this record shows
This record is dominated by education: $8,500 of the $10,811 with a category attached, or 78.6%. Intuitive Surgical accounts for 79.0% of it on its own, with 18 other manufacturers making up the rest.
Across 99 payments — averaging $109.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$9K
- Sanofi$504
- AstraZeneca$251
- Regeneron Healthcare Solutions, Inc.$199
- Grifols USA, LLC$186
- Baxter Healthcare$184
- plus $945 from 13 others
What the payments were for
- Food & beverage$2,31121%
- Education$8,50079%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 9 | $8,542 |
| Sanofi | 16 | $504 |
| AstraZeneca | 8 | $251 |
| Regeneron Healthcare Solutions, Inc. | 11 | $199 |
| Grifols USA, LLC | 8 | $186 |
| Baxter Healthcare | 7 | $184 |
| GSK | 7 | $152 |
| Mallinckrodt Hospital Products Inc. | 5 | $119 |
| Viatris Specialty LLC | 4 | $105 |
| Boehringer Ingelheim | 3 | $92 |
| Amgen | 4 | $80 |
| Verona Pharma, Inc. | 3 | $75 |
| Actelion Pharmaceuticals US, Inc. | 4 | $70 |
| Insmed, Inc. | 2 | $67 |
| Lilly USA, LLC | 2 | $50 |
| Mylan Specialty L.p. | 1 | $44 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $37 |
| Axsome Therapeutics, Inc. | 2 | $34 |
| Inspire Medical Systems, Inc. | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$8,500
How this compares
$10,811 in reported general payments places this provider in the 75th percentile of 365 pulmonary disease providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pulmonary disease in Winder
- Saad AshrafWinder$15K
- Lawrence McDermottSavannah$963K
- Vivek SambharaGainesville$417K
- Chad MillerAustell$382K
- Nehal BhattAthens$371K
- Maria MascoloRincon$358K
- Colin SwensonAtlanta$255K
- David MillerDecatur$206K
- Michael MullinsSavannah$132K
- Hitendra PatelMarietta$104K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.